Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.
Front Immunol. 2021 Nov 3;12:763412. doi: 10.3389/fimmu.2021.763412. eCollection 2021.
Front Immunol. 2021.
PMID: 34804051
Free PMC article.
Review.
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients.
Basso M, Pirola N, Pascoli S, Bragato B, Vinci A, Iannetta M, Colombo F, Geremia N, Martignago L, Rossi MC, Cipriani L, Giobbia M, Scotton PG, Parisi SG.
Basso M, et al. Among authors: cipriani l.
Vaccines (Basel). 2022 Dec 30;11(1):82. doi: 10.3390/vaccines11010082.
Vaccines (Basel). 2022.
PMID: 36679927
Free PMC article.
Item in Clipboard
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito AR, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE Study Group.
Bassetti M, et al. Among authors: cipriani l.
Int J Antimicrob Agents. 2019 Apr;53(4):408-415. doi: 10.1016/j.ijantimicag.2018.11.001. Epub 2018 Nov 8.
Int J Antimicrob Agents. 2019.
PMID: 30415002
Item in Clipboard
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study).
Bassetti M, Vena A, Giacobbe DR, Falcone M, Tiseo G, Giannella M, Pascale R, Meschiari M, Digaetano M, Oliva A, Rovelli C, Carannante N, Losito AR, Carbonara S, Mariani MF, Mastroianni A, Angarano G, Tumbarello M, Tascini C, Grossi P, Mastroianni CM, Mussini C, Viale P, Menichetti F, Viscoli C, Russo A; CEFTABUSE Study Group.
Bassetti M, et al.
Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa139. doi: 10.1093/ofid/ofaa139. eCollection 2020 May.
Open Forum Infect Dis. 2020.
PMID: 32462046
Free PMC article.
Item in Clipboard
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.
Furlan A, Forner G, Cipriani L, Vian E, Rigoli R, Gherlinzoni F, Scotton P.
Furlan A, et al. Among authors: cipriani l.
Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):e731-e735. doi: 10.1016/j.clml.2021.05.013. Epub 2021 May 21.
Clin Lymphoma Myeloma Leuk. 2021.
PMID: 34217677
Free PMC article.
Item in Clipboard
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa.
Vena A, Giacobbe DR, Mussini C, Cattelan A, Bassetti M; Ceftabuse Study Group.
Vena A, et al.
Clin Infect Dis. 2020 Oct 23;71(7):1799-1801. doi: 10.1093/cid/ciaa003.
Clin Infect Dis. 2020.
PMID: 31904819
No abstract available.
Item in Clipboard
Cite
Cite